Evaluation of two dierent vaccine platforms for immunization against melioidosis and glanders.

MLA

Biryukov, Sergei S., et al. “Evaluation of Two Dierent Vaccine Platforms for Immunization against Melioidosis and Glanders.” Frontiers in Microbiology, vol. 13, Aug. 2022, pp. 1–28. EBSCOhost, https://doi.org/10.3389/fmicb.2022.965518.

APA

Biryukov, S. S., Cote, C. K., Klimko, C. P., Dankmeyer, J. L., Rill, N. O., Shoe, J. L., Hunter, M., Shamsuddin, Z., Velez, I., Hedrick, Z. M., Rosario-Acevedo, R., Talyansky, Y., Schmidt, L. K., Orne, C. E., Fetterer, D. P., Burtnick, M. N., Brett, P. J., Welkos, S. L., & DeShazer, D. (2022). Evaluation of two dierent vaccine platforms for immunization against melioidosis and glanders. Frontiers in Microbiology, 13, 1–28. https://doi.org/10.3389/fmicb.2022.965518

Chicago

Biryukov, Sergei S., Christopher K. Cote, Christopher P. Klimko, Jennifer L. Dankmeyer, Nathaniel O. Rill, Jennifer L. Shoe, Melissa Hunter, et al. 2022. “Evaluation of Two Dierent Vaccine Platforms for Immunization against Melioidosis and Glanders.” Frontiers in Microbiology 13 (August): 1–28. doi:10.3389/fmicb.2022.965518.